A series of macrocyclic factor XIa (FXIa) inhibitors was designed based on an analysis of the crystal structures of the acyclic phenylimidazole compounds. Further optimization using structure-based design led to inhibitors with pM affinity for FXIa, excellent selectivity against a panel of relevant serine proteases, and good potency in the activated partial thromboplastin time (aPTT) clotting assay.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2017.07.048 | DOI Listing |
Publication Analysis
Top Keywords
macrocyclic factor
8
factor xia
8
xia inhibitors
4
inhibitors series
4
series macrocyclic
4
xia fxia
4
fxia inhibitors
4
inhibitors designed
4
designed based
4
based analysis
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!